查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1840725

冠状动脉支架市场按产品类型、材料、涂层、应用、最终用户和分销管道划分－2025-2032 年全球预测

Coronary Stents Market by Product Type, Material, Coating, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，冠状动脉支架市场将成长至 211.4 亿美元，复合年增长率为 10.78%。

主要市场统计数据
基准年2024年 93.1亿美元
预计2025年 103亿美元
预测年份：2032年 211.4亿美元
复合年增长率（%） 10.78%

介绍性概述，重点介绍影响冠状动脉支架采用和采购的设备类别、临床要求和策略价值槓桿

冠状动脉支架领域正处于快速临床创新与不断发展的交付模式的交汇点，因此需要一个入门框架来阐明其范围、术语和战略要点。本介绍概述了最新的器械类别、材料科学的进展、操作考虑以及影响介入性心臟病学技术应用的相关人员生态系统。透过区分传统设计和新一代平台，并解释临床证据、报销动态和医院采购惯例如何共同影响器械选择，从而建立基础理解。

引言也将冠状动脉支架纳入了急性冠状动脉症候群的更广泛治疗途径，强调经经皮冠状动脉介入治疗仍然是最小化梗塞面积、恢復灌注和改善长期疗效的核心。引言从行业角度探讨了聚合物技术、药物释放型曲线和支架设计的逐步改进如何有助于减少血管再阻塞和改善内皮化，并强调了监管和强有力的上市后监测的必要性。

最后，引言透过确定製造商和医疗保健系统的关键价值槓桿（临床差异化、成本效率、供应链弹性和证据生成）为其余分析组装，为后续章节探讨转型转变、关税影响、细分洞察和区域差异奠定了基础，使读者在阅读报告时有一个明确的目的。

近期的设备创新、采购演变和数据主导的临床模型如何重新定义冠状动脉支架领域的竞争差异化

过去五年，器械设计、监管预期和通路动态的变革正在重塑冠状动脉支架领域的竞争格局。生物可吸收支架化学和低剖面输送系统的进步，更重视长期血管癒合和晚期管腔预后，迫使临床医生重新评估器械选择标准，而不仅仅是短期手术成功率。同时，聚合物创新正在实现更一致的药物洗脱动力学，降低血管再阻塞率，并支持第二代药物洗脱平台的广泛应用。

同时，付款方和医院的筹资策略也变得更加复杂，强调总成本和基于价值的合同，而不仅仅是单位成本。这种转变有利于那些能够证明持久临床效益、可预测库存管理和灵活商业模式（包括直销和经销商合作）的製造商。此外，门诊手术中心和门诊介入室的兴起，也催生了对精简库存套件和设备的需求，这些套件和设备能够支援快速週转、高效灭菌和简单的临床医生培训。

最后，数位健康与数据驱动的上市后监测的整合正在改变竞争动态。能够提供远端监控、註册支援和真实世界证据管道的製造商正在赢得循环系统领导者和付款人的信任。因此，市场正在从单纯的设备功能竞争转向将临床结果与提供者效率相结合的整合服务模式的竞争。

评估2025年美国关税调整如何增强供应链策略、采购本地化和采购总成本考量

2025年美国关税政策的转变，为製造商、经销商和医院采购团队的营运环境带来了新的变数。其累积效应进一步凸显了供应链弹性、采购多角化和贴近市场的製造能力的重要性。重要的是，虽然关税并未改变临床表现预期，但它确实改变了跨境采购的经济性，并改变了关键零件和成品产地的计算方式。

因此，许多相关人员正在加快供应商资格审查流程，以确保供应的连续性，并降低投入成本突然波动的风险。这促使人们重新重视有效的多源采购策略和区域製造布局，以降低关税波动带来的风险。同时，采购部门正在进行更详细的总拥有成本分析，将关税、物流和库存持有成本纳入考量，并日益严格地审查与直销团队和分销商合作伙伴签订的合约条款。

临床医生和医院管理人员对此的回应是，优先考虑兼具临床可靠性和可预测供应的设备组合。因此，能够提供透明采购路线图、本地化计划和强大服务水准协议的製造商正受到更青睐。最后，关税环境促使人们讨论战略伙伴关係和联合製造安排，以稳定供应，同时确保负责人和患者能够获得最尖端科技。

整合细分洞察，将产品设计、材料科学、涂层策略、临床应用、最终用户需求和分销模式连结起来，实现策略协调

特定细分市场的动态揭示了产品设计、材料成分、涂层策略、临床应用、最终用户设定和通路等方面的差异化需求向量。按产品类型划分，裸金属支架在某些需要简单支架和低成本解决方案的临床场景中仍然发挥着传统作用，而生物可吸收血管支架因其具有随时间推移恢復原生血管生理功能的潜力而越来越受到人们的关注。药物释放型支架在复杂病变中仍然占主导地位，而聚合物涂层支架则根据洗脱药物进一步细分，例如Everolimus、Sirolimus和佐他莫司。无聚合物选项适用于对耐用聚合物敏感的患者。钴铬合金在强度和渗透性之间取得平衡，而镍钛诺则提供超弹性，非常适合曲折的解剖结构。当成本和可製造性是主要考虑因素时，不銹钢是首选。

涂层策略与聚合物科学和药物化学相互交织，决定了癒合反应和血管再阻塞风险。当控制释放至关重要时，聚合物涂层器械仍然很受欢迎；无聚合物支架则吸引寻求减少聚合物暴露的特定患者群体；而无涂层平台则专用于特定适应症，这些适应症优先考虑机械支撑而无需药物调整。用于急性心肌梗塞的器械必须优先考虑快速部署和抗血栓性，而用于慢性冠状动脉疾病的平台则强调长期通畅性和治疗后安全性。门诊手术中心优先考虑紧凑的库存和便捷性，心臟中心需要利基专用器械，而医院则需要广泛的SKU深度和即时用于紧急干预的库存。分销管道决定了商业执行，因为直销可以实现密切的临床参与和培训，分销商提供广泛的覆盖范围和库存管理，而线上管道越来越多地支持机构买家补货和产品资讯。这些细分市场之间的相互作用构成了一个复杂的矩阵，製造商必须驾驭它，以使产品设计、临床证据产生和上市模式与相关人员的需求保持一致。

美洲、欧洲、中东和非洲以及亚太地区的战略需求和差异化的市场动态推动了采用和商业性执行

区域动态对冠状动脉支架的临床实务模式、监管途径和商业性执行有重大影响。在美洲，介入性心臟病学的卓越中心、密集的医院网络以及以结果为导向的支付方，为先进的药物释放型平台和强大的上市后证据项目创造了肥沃的土壤。该地区的采购週期往往强调捆绑式医疗指标，因此临床数据和服务交付成为谈判的关键要素。由于公立和私立医院在某些市场优先考虑成本控制，而在其他市场则对尖端医疗设备的需求旺盛，製造商必须调整其价值文件和本地临床伙伴关係关係，以满足国家层面的期望。

在亚太地区，手术量的快速增长、介入服务覆盖范围的不断扩大以及多样化的医疗服务模式既带来了机会，也带来了营运的复杂性。本地製造和战略许可在该地区尤其重要，因为监管时间表和进口考虑会影响采用速度。在每个地区，都市区三级医疗中心与分散服务之间的互动都会影响SKU的合理化和培训投资。因此，商业策略必须因地制宜，在集中式临床证据产生和分散式执行能力之间取得平衡，以优化采用率并与医疗系统和临床医生保持长期合作关係。

主要企业如何结合临床证据、製造敏捷性和多通路商业模式来确保竞争优势和医疗保健提供者的信任

冠状动脉支架生态系统的主要企业透过临床证据、材料创新、商业卓越和服务的结合脱颖而出。投资于随机试验和大规模註册的领先製造商能够提升临床医生的信心和医院的接受度，而那些透过培训计划和数据管理服务补充其设备产品的製造商则能够提高其在复杂治疗中心的渗透率。设备製造商和契约製造製造商之间的策略联盟加快了新合金和涂层製程的上市时间，并使其能够更灵活地回应临床医生的回馈和监管咨询。

此外，竞争优势也越来越依赖多通路交付。成功将直销与经销商网路和数位订购平台结合的公司能够实现更广泛的覆盖范围和更稳定的库存绩效。其他公司则利用本地生产和区域监管专业知识来缩短订单前置作业时间。总而言之，差异化不在于单一产品的优势，而是提供一致临床结果、可靠的供应连续性以及将设备整合到医疗机构工作流程中的支援性服务模式的能力。

为设备製造商和商业领袖提供高影响力的建议，以增强临床差异化、供应弹性和基于价值的采用

针对行业领导者的可行建议强调了加强临床差异化、供应弹性和商业性相关性的切实步骤：投资于註册研究和有针对性的随机试验，这些研究应在代表性患者群体中证明疗效持久且具有成本效益。其次，实现生产和供应网络多元化，以减少贸易政策变化和物流中断带来的风险，同时保持严格的品质系统和透明的采购资讯揭露，以安抚机构投资者。

第三，我们将根据不同的临床和最终用户需求调整产品系列，将设备特性（例如聚合物策略、药物洗脱曲线和材料成分）与最利于采用的程序环境相结合。第四，我们将扩展商业模式，包括多站点直销、与经销商合作以扩大覆盖范围，以及用于续药和产品教育的数位平台。第五，我们将投资于上市后监测和数位工具，以产生真实世界证据并支持临床医生培训。最后，我们将促进支付方和医疗系统之间的协作对话，从整体护理角度而非单位成本来看待医疗设备，从而促成​​对可证明的临床和经济价值进行奖励的协议。实施这些措施将提高市场韧性，并使我们能够实现持续的临床应用。

采用稳健的混合方法研究途径，结合临床医师访谈、指南综合、监管审查和商业管道分析来检验结论

本报告背后的调查方法结合了专家定性访谈、系统性文献评估、监管文件审查和跨职能商业分析，以确保获得均衡且检验的见解。主要研究包括与介入性心臟病专家、医院采购主管、分销主管和报销专家的对话，以了解他们在器械选择、临床重点和营运限制方面的专业观点。这些相关人员的意见与同行评审的临床文献、主要心臟病学会指南和公共监管资讯进行了整合，以检验临床声明并识别新兴的安全讯号。

我们的商业分析使用匿名供应商和经销商资料来绘製典型的市场进入模式、SKU策略和通路绩效考量，而我们的供应链研究则结合了采购模式和製造足迹，以评估不断变化的贸易条件下的韧性。我们谨慎地剔除了专有或机密数据，所有解读均基于可公开检验的资讯来源和专家佐证。在整个调查方法中，我们优先考虑假设的透明度、细分的清晰度和分析步骤的可重复性，以确保我们的研究结果能够可靠地应用于策略、采购和临床规划。

总结性结论强调了临床表现、交付策略和服务整合如何决定长期采用和机构价值

总而言之，冠状动脉支架产业正处于关键时刻，材料科学、聚合物技术和证据生成与不断变化的采购和监管格局交汇。持久的疗效、减少血管再阻塞以及良好的癒合情况将持续影响心臟科医师的偏好。同时，供应链弹性、总拥有成本和区域监管复杂性等经济和营运因素对医院和系统采购商也日益具有决定性作用。

因此，将产品创新与已证实的临床效用、透明的供应策略和服务导向的商业模式相结合的相关人员，将最有可能实现永续的采用。对本地製造、真实世界证据产生和售后整合支援的策略性投资将创造稳固的优势。最终，市场将青睐那些能够提供可预测临床结果，同时无缝融入机构工作流程和付款人期望的解决方案，确保患者受益并实现机构价值。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 增加生物可吸收镁支架的采用可降低长期血栓症风险
  • 整合药物释放型涂层创新技术，标靶治疗复杂冠状动脉病变
  • 扩大机器人辅助经皮冠状动脉介入治疗可提高准确性
  • 同时治疗血管再阻塞和癒合的双疗支架的需求不断增加
  • 使用 3D 成像和 AI 演算法进行患者特异性支架尺寸测量的进展
  • 细支柱钴铬支架的市场渗透率提高输送能力
  • 监管部门的核准扩大了下一代可生物降解聚合物支架的机会
  • 中国和印度扩大公共卫生计画对冠状动脉支架消费的影响
  • 支架置入后患者追踪的远端监控和数位健康平台的演变
  • 低成本支架製造商之间的竞争趋势将影响定价策略

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 冠状动脉支架市场（依产品类型）

  • 裸金属支架
  • 生物可吸收血管支架
  • 药物释放型支架
    • 聚合物涂层
      • Everolimus洗脱
      • Sirolimus洗脱
      • 佐他莫司洗脱
    • 不含聚合物

9. 冠状动脉支架市场（依材料）

  • 钴铬合金
  • 镍钛合金
  • 不銹钢

10. 冠状动脉支架市场（按涂层）

  • 聚合物涂层
  • 不含聚合物
  • 无涂层

第11章 冠状动脉支架市场（依应用）

  • 急性心肌梗塞
  • 慢性冠状动脉疾病

第12章 冠状动脉支架市场（依最终用户）

  • 门诊手术中心
  • 心臟中心
  • 医院

13. 冠状动脉支架市场（依通路）

  • 直销
  • 经销商
  • 在线的

14. 冠状动脉支架市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 15 章：冠状动脉支架市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国心臟支架市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic plc
    • Terumo Corporation
    • Biotronik SE & Co. KG
    • Cordis Corporation
    • B. Braun Melsungen AG
    • MicroPort Scientific Corporation
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Cook Medical LLC
Product Code: MRR-A339DAEFA3E2

The Coronary Stents Market is projected to grow by USD 21.14 billion at a CAGR of 10.78% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 9.31 billion
Estimated Year [2025] USD 10.30 billion
Forecast Year [2032] USD 21.14 billion
CAGR (%) 10.78%

Introductory overview that clarifies device categories, clinical imperatives, and strategic value levers shaping adoption and procurement of coronary stents

The coronary stent landscape sits at the intersection of rapid clinical innovation and evolving delivery models, requiring an introductory framing that clarifies scope, terminology, and strategic imperatives. This introduction outlines the contemporary device classes, material science advances, procedural considerations, and the ecosystem of stakeholders that shape technology adoption across interventional cardiology. It establishes a baseline understanding by distinguishing between legacy designs and next-generation platforms, and by explicating how clinical evidence, reimbursement dynamics, and hospital procurement practices converge to influence device selection.

In addition, the introduction situates coronary stents within broader care pathways for acute and chronic coronary syndromes, highlighting how percutaneous coronary intervention remains central to minimizing infarct size, restoring perfusion, and improving long-term outcomes. From an industry perspective, the introduction discusses how incremental improvements in polymer technology, drug elution profiles, and scaffold design contribute to reduced restenosis and improved endothelialization, while also noting regulatory scrutiny and the need for robust post-market surveillance.

Finally, the introduction frames the remainder of the analysis by identifying the principal value levers for manufacturers and health systems: clinical differentiation, cost-effectiveness, supply chain resilience, and evidence generation. This sets expectations for the subsequent sections that explore transformative shifts, tariff impacts, segmentation insights, and regional variations, enabling readers to navigate the report with clarity and purpose.

How recent device innovations, procurement evolution, and data-driven clinical models are collectively redefining competitive differentiation in the coronary stent sector

The past five years have produced transformative shifts in device design, regulatory expectations, and channel dynamics that are reshaping competitive positioning across the coronary stent arena. Advances in bioresorbable scaffold chemistry and low-profile delivery systems have intensified the focus on long-term vascular healing and late lumen outcomes, prompting clinicians to reassess device selection criteria beyond acute procedural success. At the same time, polymer innovations have enabled more consistent drug elution kinetics, reducing rates of restenosis and supporting broader adoption of second-generation drug eluting platforms.

Concurrently, payer and hospital procurement strategies have become more sophisticated, emphasizing total cost of care and value-based contracting rather than unit price alone. This shift has favored manufacturers that can demonstrate durable clinical benefits, predictable inventory management, and flexible commercial models that include direct sales and distributor partnerships. Moreover, the rise of ambulatory surgical centers and outpatient interventional suites has created demand for streamlined inventory sets and devices that support rapid turnover, sterilization efficiency, and straightforward clinician training.

Finally, digital health integrations and data-enabled post-market surveillance are altering competitive dynamics. Manufacturers that can offer remote monitoring, registry support, and real-world evidence pipelines are gaining credibility with cardiology leaders and payers alike. As a result, the market is transitioning from competition on device features alone to competition on integrated service models that align clinical outcomes with institutional efficiency.

Assessment of how United States tariff adjustments in 2025 have intensified supply chain strategy, sourcing localization, and procurement total cost considerations

Policy shifts in 2025 regarding United States tariffs have introduced a new variable into the operating environment for manufacturers, distributors, and hospital procurement teams. The cumulative effect has been to sharpen the focus on supply chain resilience, sourcing diversification, and the importance of near-market manufacturing capabilities. Importantly, tariffs have not altered clinical performance expectations, but they have changed the economics of cross-border sourcing and the calculus for where to manufacture critical components and finished devices.

Consequently, many stakeholders have accelerated supplier qualification processes to ensure continuity of supply and to mitigate the risk of sudden input cost variability. This has led to a renewed emphasis on validated multi-sourcing strategies and regional manufacturing footprints that reduce exposure to tariff volatility. In parallel, procurement organizations have engaged in more detailed total cost of ownership analyses to account for duty, logistics, and inventory carrying costs, leading to greater scrutiny of contractual terms with both direct sales teams and distributor partners.

Clinicians and hospital administrators have reacted by prioritizing device portfolios that combine clinical reliability with predictable supply. As a result, manufacturers that can offer transparent sourcing maps, localization plans, and robust service-level agreements are being viewed more favorably. Finally, the tariff environment has encouraged conversations about strategic partnerships and co-manufacturing arrangements to stabilize supply while preserving access to cutting-edge technologies for proceduralists and patients.

Integrated segmentation insights that connect product design, material science, coating strategies, clinical applications, end-user requirements, and distribution models for strategic alignment

Segment-specific dynamics reveal differentiated demand vectors across product design, material composition, coating strategy, clinical application, end-user setting, and distribution pathways. By product type, the legacy role of bare metal stents persists in certain clinical scenarios where simple scaffolding and low-cost solutions are required, while bioresorbable vascular scaffolds attract interest for their potential to restore native vessel physiology over time; drug eluting stents continue to dominate adoption for complex lesions, with polymer-coated variants further segmented by eluted agents such as everolimus, sirolimus, and zotarolimus, and with polymer-free options positioned for patients with heightened sensitivity to durable polymers. Material choice matters for deliverability and radial strength, with cobalt chromium delivering a balance of strength and radiopacity, nitinol offering superelastic properties favorable for tortuous anatomies, and stainless steel remaining relevant where cost and manufacturability are primary considerations.

Coating strategy intersects with polymer science and drug chemistry to determine healing response and restenosis risk; polymer-coated devices remain prevalent where controlled release is paramount, polymer-free stents appeal in select patient cohorts seeking reduced polymer exposure, and uncoated platforms are reserved for specific indications that prioritize mechanical support without pharmacologic modulation. Application-level segmentation highlights distinct clinical decision trees: devices used for acute myocardial infarction must prioritize rapid deployability and thrombus tolerance, whereas platforms for chronic coronary artery disease emphasize long-term patency and late-outcome safety. End-use environments influence purchasing behavior and inventory management, with ambulatory surgical centers prioritizing compact inventory and simplicity, cardiac centers requiring niche specialty devices, and hospitals demanding broad SKU depth and immediate availability for emergency interventions. Distribution channels shape commercial execution, as direct sales enable close clinical engagement and training, distributors offer breadth of reach and inventory management, and online channels increasingly support replenishment and product information for institutional buyers. Taken together, these segment interactions create an intricate matrix that manufacturers must navigate to align product design, clinical evidence generation, and go-to-market models with stakeholder needs.

Regional strategic imperatives and differentiated market dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive adoption and commercial execution

Regional dynamics exert a profound influence on clinical practice patterns, regulatory pathways, and commercial execution for coronary stents. In the Americas, centers of excellence in interventional cardiology, dense hospital networks, and payers focused on outcomes create fertile ground for advanced drug eluting platforms and robust post-market evidence programs. Procurement cycles in this region tend to emphasize bundled care metrics, making clinical data and service offerings pivotal in negotiations. Moving to Europe, the Middle East & Africa, the regulatory heterogeneity and varied reimbursement landscapes require adaptable market entry strategies; public and private hospitals may prioritize cost containment in some markets while seeking cutting-edge devices in others, so manufacturers must calibrate value dossiers and local clinical partnerships to match country-level expectations.

In the Asia-Pacific region, rapid growth in procedural volumes, expanding access to interventional services, and a diverse mix of healthcare delivery models present both opportunities and operational complexities. Local manufacturing and strategic licensing are especially salient in this region, where regulatory timelines and import considerations can influence adoption speed. Across all regions, the interplay between urban tertiary centers and distributed rural services affects SKU rationalization and training investments. Therefore, commercial strategies should be regionally nuanced, balancing centralized clinical evidence generation with decentralized execution capabilities to optimize adoption and sustain long-term relationships with health systems and clinicians.

How leading companies are combining clinical evidence, manufacturing agility, and multi-channel commercial models to secure competitive advantage and institutional trust

Key companies in the coronary stent ecosystem differentiate themselves through a combination of clinical evidence, material innovation, commercialization sophistication, and service delivery. Leading manufacturers that invest in randomized trials and large registries generate stronger clinician trust and facilitate hospital formulary acceptance, while those that complement device offerings with training programs and data-management services achieve greater penetration in complex treatment centers. Strategic alliances between device makers and contract manufacturers have accelerated time-to-market for novel alloys and coating processes, enabling more agile responses to clinician feedback and regulatory queries.

Moreover, competitive advantage increasingly depends on multi-channel reach; companies that successfully integrate direct sales engagement with distributor networks and digital ordering platforms achieve broader coverage and more consistent inventory performance. Several firms are also leveraging localized production and regional regulatory expertise to reduce order lead times and improve price competitiveness in import-sensitive markets. Finally, firms that offer comprehensive lifecycle support, including warranty programs, clinician education, and post-market surveillance, are perceived as lower operational risk by procurement teams. In sum, company differentiation is less about single product superiority and more about the ability to deliver consistent clinical outcomes, reliable supply continuity, and supportive service models that embed the device into institutional workflows.

High-impact recommendations for device manufacturers and commercial leaders to strengthen clinical differentiation, supply resilience, and value-based adoption

Actionable recommendations for industry leaders emphasize pragmatic steps to strengthen clinical differentiation, supply resilience, and commercial relevance. First, prioritize evidence generation that aligns with payer metrics and hospital value frameworks; invest in registries and targeted randomized studies that demonstrate durable outcomes and cost-effectiveness in representative patient cohorts. Second, diversify manufacturing and supplier networks to reduce exposure to trade policy shifts and logistic disruptions, while maintaining rigorous quality systems and transparent sourcing disclosures to reassure institutional buyers.

Third, tailor product portfolios to distinct clinical and end-user needs by aligning device features-such as polymer strategy, drug elution profile, and material composition-with the procedural settings most relevant to adoption. Fourth, expand commercial models to include a mix of direct sales for complex centers, distributor partnerships for broad reach, and digital platforms for replenishment and product education. Fifth, invest in post-market surveillance and digital tools that produce real-world evidence and support clinician training; these capabilities enhance formulary acceptance and support long-term outcomes tracking. Finally, cultivate collaborative payer and health-system dialogues that frame devices in total care terms rather than unit price, enabling agreements that reward demonstrable clinical and economic value. Implementing these measures will improve market resilience and position organizations to capture sustained clinical adoption.

Robust mixed-method research approach combining clinician interviews, guideline synthesis, regulatory review, and commercial channel analysis to validate conclusions

The research methodology underpinning this report combines qualitative expert interviews, systematic literature appraisal, regulatory document review, and cross-functional commercial analysis to ensure balanced and verifiable insights. Primary engagement included conversations with interventional cardiologists, hospital procurement leaders, distribution executives, and reimbursement specialists to capture frontline perspectives on device selection, clinical priorities, and operational constraints. These stakeholder inputs were triangulated with peer-reviewed clinical literature, guidelines from major cardiology societies, and public regulatory communications to validate clinical assertions and identify emerging safety signals.

Commercial analysis used anonymized supplier and distributor data to map typical go-to-market models, SKU strategies, and channel performance considerations, while supply chain examination incorporated sourcing patterns and manufacturing footprints to assess resilience under changing trade conditions. Care was taken to exclude proprietary or confidential data, and all interpretations were grounded in publicly verifiable sources and subject-matter expert corroboration. Throughout, the methodology prioritized transparency in assumptions, clarity in segmentation, and reproducibility of analytic steps so that findings can inform strategy, procurement, and clinical planning with confidence.

Concluding synthesis highlighting how clinical performance, supply strategy, and service integration together determine long-term adoption and institutional value

In conclusion, the coronary stent sector is navigating a pivotal phase where material science, polymer technology, and evidence generation converge with evolving procurement and regulatory contexts. The clinical imperative remains the primary driver of device selection: durable outcomes, reduced restenosis, and favorable healing profiles will continue to influence cardiologist preference. At the same time, economic and operational factors such as supply chain resilience, total cost of ownership, and regional regulatory complexity are increasingly decisive for hospital and system buyers.

Therefore, stakeholders that align product innovation with demonstrable clinical benefit, transparent supply strategies, and service-oriented commercial models will be best placed to achieve sustainable adoption. Strategic investments in localized manufacturing, real-world evidence generation, and integrated post-sale support will create defensible advantages. Ultimately, the market rewards solutions that deliver predictable clinical outcomes while fitting seamlessly into institutional workflows and payer expectations, ensuring both patient benefit and institutional value realization.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of bioresorbable magnesium stents reducing long-term thrombosis risk
  • 5.2. Integration of drug-eluting coating innovations targeting complex coronary lesions
  • 5.3. Expansion of robotic-assisted percutaneous coronary interventions improving precision
  • 5.4. Growing demand for dual therapy stents addressing restenosis and healing simultaneously
  • 5.5. Advancements in patient-specific stent sizing aided by 3D imaging and AI algorithms
  • 5.6. Market penetration of thin strut cobalt chromium stents enhancing deliverability
  • 5.7. Regulatory approvals shaping opportunities for next-generation biodegradable polymer stents
  • 5.8. Impact of China and India expanding public health programs on coronary stent consumption
  • 5.9. Evolution of remote monitoring and digital health platforms for post-stenting patient follow-up
  • 5.10. Competitive dynamics from low-cost stent manufacturers influencing pricing strategies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Stents Market, by Product Type

  • 8.1. Bare Metal Stents
  • 8.2. Bioresorbable Vascular Scaffold
  • 8.3. Drug Eluting Stents
    • 8.3.1. Polymer Coated
      • 8.3.1.1. Everolimus Eluting
      • 8.3.1.2. Sirolimus Eluting
      • 8.3.1.3. Zotarolimus Eluting
    • 8.3.2. Polymer Free

9. Coronary Stents Market, by Material

  • 9.1. Cobalt Chromium
  • 9.2. Nitinol
  • 9.3. Stainless Steel

10. Coronary Stents Market, by Coating

  • 10.1. Polymer Coated
  • 10.2. Polymer Free
  • 10.3. Uncoated

11. Coronary Stents Market, by Application

  • 11.1. Acute Myocardial Infarction
  • 11.2. Chronic Coronary Artery Disease

12. Coronary Stents Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Cardiac Centers
  • 12.3. Hospitals

13. Coronary Stents Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. Coronary Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Coronary Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Coronary Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Boston Scientific Corporation
    • 17.3.3. Medtronic plc
    • 17.3.4. Terumo Corporation
    • 17.3.5. Biotronik SE & Co. KG
    • 17.3.6. Cordis Corporation
    • 17.3.7. B. Braun Melsungen AG
    • 17.3.8. MicroPort Scientific Corporation
    • 17.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
    • 17.3.10. Cook Medical LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CORONARY STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CORONARY STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CORONARY STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CORONARY STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CORONARY STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY STENTS MARKET SIZE, BY EVEROLIMUS ELUTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY STENTS MARKET SIZE, BY SIROLIMUS ELUTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY STENTS MARKET SIZE, BY ZOTAROLIMUS ELUTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER COATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CORONARY STENTS MARKET SIZE, BY UNCOATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE MYOCARDIAL INFARCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CORONARY STENTS MARKET SIZE, BY CHRONIC CORONARY ARTERY DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CORONARY STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CORONARY STENTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CORONARY STENTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY STENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS CORONARY STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS CORONARY STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL CORONARY STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. GCC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. GCC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. GCC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. GCC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. GCC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 324. GCC CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 325. GCC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2018-2024 (USD MILLION)
  • TABLE 326. GCC CORONARY STENTS MARKET SIZE, BY POLYMER COATED, 2025-2032 (USD MILLION)
  • TABLE 327. GCC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 328. GCC CORONARY STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 329. GCC CORONARY STENTS MARKET SIZE, BY COATING, 2018-2024 (USD MILLION)
  • TABLE 330. GCC CORONARY STENTS MARKET SIZE, BY COATING, 2025-2032 (USD MILLION)
  • TABLE 331. GCC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. GCC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. GCC CORONARY STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. GCC CORONARY STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. GCC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. GCC CORONARY STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION CORONARY STENTS MARKET SIZE, BY DRUG ELUTING STENTS, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION CORONARY STENTS MARKET SIZ